The schizophrenia phenotype in 22q11 deletion syndrome

American Journal of Psychiatry

Volumn 160, Issue 9, 2003, Pages 1580-1586

  Bassett, Anne S ^a   Chow, Eva W C ^b   AbdelMalik, Philip ^b   Gheorghiu, Mirona ^b   Husted, Janice ^b   Weksberg, Rosanna ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BRAIN DEVELOPMENT; CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME DELETION 22Q; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EXCITEMENT; EXPERIMENTAL MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; ONSET AGE; PHENOTYPE; PRECURSOR; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RARE DISEASE; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL PSYCHIATRY; SUBSTANCE ABUSE; SYNDROME; ADDICTION; ANXIETY DISORDER; CHROMOSOME 22; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MALE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; AGE OF ONSET; ANXIETY DISORDERS; CHROMOSOMES, HUMAN, PAIR 22; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 0346322914     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.9.1580     Document Type: Article

References (39)

1. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44:660-669
2. Bassett AS, Chow EWC, O'Neill S, Brzustowicz LM: Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull 2001; 27:417-430
3. Bassett AS, Chow EWC: 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999; 46:882-891
4. Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56:940-945
5. Bassett AS, Hodgkinson K, Chow EWC, Correia S, Scutt LE, Weksberg R: 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet Neuropsychiatr Genet 1998; 81:328-337
6. Scutt L, Chow EWC, Weksberg R, Honer WG, Bassett AS: Patterns of dysmorphic features in schizophrenia. Am J Med Genet Neuropsychiatr Genet 2001; 105:713-723
7. Chow EWC, Mikulis DJ, Zipursky RB, Scutt LE, Weksberg R, Bassett AS: Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 1999; 46:1436-1442
8. Swillen A, Vogels A, Devriendt K, Fryns JP: Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 2000; 97:128-135
9. Bassett AS, Chow EWC, Weksberg R: Chromosomal abnormalities and schizophrenia. Am J Med Genet Semin Med Genet 2000; 97:45-51
10. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, Shprintzen R, Kucherlapati R, Morrow B: Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 1997; 60:851-859
11. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarakis SE, Pulver AE, Housman DE: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 1995; 92:7612-7616
12. Goodship J, Cross I, LiLing J, Wren C: A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 1998; 79:348-351
13. Gothelf D, Frisch A, Munitz H, Rockah R, Laufer N, Mozes T, Hermesh H, Weizman A, Frydman M: Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 1999; 35:105-112
14. Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel BS: Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993; 30:813-817
15. Cohen E, Chow EWC, Weksberg R, Bassett AS: Phenotype of adults with the 22q11 deletion syndrome: a review. Am J Med Genet 1999; 86:359-365
16. Bassett AS, Collins EJ, Nuttall SE, Honer WG: Positive and negative symptoms in families with schizophrenia. Schizophr Res 1993; 11:9-19
17. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS: Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000; 288:678-682
18. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC, American Psychiatric Press, 1990
19. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Administration Booklet. Washington, DC, American Psychiatric Press, 1997
20. Silverstein AB: Two- and four-subtest short forms of the Wechsler Adult Intelligence Scale - Revised. J Consult Clin Psychol 1982; 50:415-418
21. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
22. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
23. Lindenmayer J-P, Bernstein-Hyman R, Grochowski S, Bark N: Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 1995; 28:22-31
24. Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer J-P, McEvoy J, Cooper TB, Chakos M, Lieberman JA: Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv 2001; 52:1510-1514
25. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
26. Fleck DE, Sax KW, Strakowski SM: Reaction time measures of sustained attention differentiate bipolar disorder from schizophrenia. Schizophr Res 2001; 52:251-259
27. Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C Jr, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF: Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157:982-986
28. Simonoff E, Bolton P, Rutter M: Mental retardation: genetic findings, clinical implications and research agenda. J Child Psychol Psychiatry 1996; 37:259-280
29. Reiss AL, Eliez S, Schmitt JE, Patwardhan A, Haberecht M: Brain imaging in neurogenetic conditions: realizing the potential of behavioral neurogenetics research. Ment Retard Dev Disabil Res 2000; 6:186-197
30. Doody GA, Johnstone EC, Sanderson TL, Cunningham Owens DG, Muir WJ: "Pfropfschizophrenie" revisited: schizophrenia in people with mild learning disability. Br J Psychiatry 1998; 173:145-153
31. Nicolson R, Giedd JN, Lenane M, Hamburger S, Singaracharlu S, Bedwell J, Fernandez T, Thaker GK, Malaspina D, Rapoport JL: Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia. Am J Psychiatry 1999; 156:1575-1579
32. St. George-Hyslop PH: Molecular genetics of Alzheimer's disease. Biol Psychiatry 2000; 47:183-199
33. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349:704-706
34. Heston L, Mastri A: The genetics of Alzheimer's disease: associations with hematologic malignancy and Down's syndrome. Arch Gen Psychiatry 1977; 34:976-981
35. Robakis N, Wisniewski H, Jenkins E, Devine-Gage E, Houck G, Yao X-L, Ramakrishna N, Wolfe G, Silverman W, Brown W: Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet 1987; 1:384-385
36. Davison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature, in Current Problems in Neuropsychiatry: Schizophrenia, Epilepsy, the Temporal Lobe. Edited by Herrington RN. London, Headley, 1969, pp 113-184
37. Chow EWC, Zipursky RB, Mikulis DJ, Bassett AS: Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry 2002; 51:208-215
38. Feinstein C, Eliez S, Blasey C, Reiss AL: Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 2002; 51:312-318
39. Graf WD, Unis AS, Yates CM, Sulzbacher S, Dinulos MB, Jack RM, Dugaw KA, Paddock MN, Parson WW: Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology 2001; 57:410-416